Evidence for infectious agents in cardiovascular disease and atherosclerosis.
about
Chlamydia inhibit host cell apoptosis by degradation of proapoptotic BH3-only proteinsHuman immunodeficiency virus impairs reverse cholesterol transport from macrophages.Chlamydophila pneumoniae Infection and Its Role in Neurological Disorders.Evaluation of the effect of andrographolide on atherosclerotic rabbits induced by Porphyromonas gingivalisPersistent Chlamydophila pneumoniae infection in thoracic aortic aneurysm and aortic dissection?Cytomegalovirus infection in association with early onset pre-eclampsia.Uremia and chronic kidney disease: the role of the gut microflora and therapies with pro- and prebiotics.Welcome to Herpesviridae -- a new premier virology journal.Inhibitory activity of the isoflavone biochanin A on intracellular bacteria of genus Chlamydia and initial development of a buccal formulation.Lipid Metabolism and Cardiovascular Risk in HIV-1 Infection and HAART: Present and Future Problems.Development potential of rifalazil.Platelet-activating factor levels of serum and gingival crevicular fluid in nonsmoking patients with periodontitis and/or coronary heart disease.Update on general health risk of periodontal disease.The increasing impact of laboratory medicine on clinical cardiology.Psychological stress in childhood and susceptibility to the chronic diseases of aging: moving toward a model of behavioral and biological mechanisms.Increased serum concentrations of soluble CD95/Fas and caspase 1/ICE in patients with acute angina.Paraoxonase-2 modulates stress response of endothelial cells to oxidized phospholipids and a bacterial quorum-sensing molecule.Immunomodulation and vaccination for atherosclerosis.In silico analyses of metagenomes from human atherosclerotic plaque samples.Toll-like receptors in the pathogenesis of human disease.Mammalian Toll-like receptors: to immunity and beyond.Determinants of lumbar artery occlusion among patients with sciatica: a three-year follow-up with magnetic resonance angiography.Association of Chlamydia pneumoniae infection with HLA-B*35 in patients with coronary artery disease.Toll-like receptor modulation in cardiovascular disease: a target for intervention?Chlamydia pneumoniae and age-related macular degeneration: a role in pathogenesis or merely a chance association?Cardiovascular biomarkers: increasing impact of laboratory medicine in cardiology practice.Persistent pathogens linking socioeconomic position and cardiovascular disease in the US.Do genetic factors explain the association between poor oral health and cardiovascular disease? A prospective study among Swedish twins.Dendritic cells and their role in atherogenesis.Cholesterol uptake in the mouse aorta increases during Chlamydia pneumoniae infection.Endothelial cell death and intimal foam cell accumulation in the coronary artery of infected hypercholesterolemic minipigs.The association of body mass index, waist and hip circumference, and waist-hip ratio with Chlamydia pneumoniae IgG antibodies and high-sensitive C-reactive protein at 31 years of age in Northern Finland Birth Cohort 1966.Infection-induced coronary dysfunction and systemic inflammation in piglets are dampened in hypercholesterolemic milieu.Interleukin-6-174 G/C promoter polymorphism is associated with persistence of Chlamydia pneumoniae antibodies in young men.Chlamydia pneumoniae infection is associated with elevated body mass index in young men.Beneficial effect of clarithromycin in patients with acute coronary syndrome and complement C4 deficiencies.Chlamydia pneumoniae DNA is present in peripheral blood mononuclear cells during acute coronary syndrome and correlates with chlamydial lipopolysaccharide levels in serum.Chlamydial LPS and high-sensitivity CRP levels in serum are associated with an elevated body mass index in patients with cardiovascular disease.Maternal serum Chlamydia pneumoniae antibodies and CRP levels in women with preeclampsia and gestational hypertension.The effect of Chlamydia pneumoniae on the expression of peroxisome proliferator-activated receptor-gamma in vascular smooth muscle cells
P2860
Q24645975-A2015EB8-3A5A-44B8-B4C8-A6AF1A60A93AQ33262244-0E441C86-7D8E-418B-BDFD-602DE2DF3FEEQ33674644-9189F152-6827-4723-9C63-0E838F1C7200Q34120640-CA722F75-C898-467C-8BF0-5FAFE875963CQ34128118-9855FEFD-DDF6-433E-B723-69B46BB15B84Q34536248-42239C30-89C2-4B69-B696-CEC483E8A36DQ34602194-01CA8BE8-96FC-411D-973B-66E49A296E13Q34631642-A068AEBB-A277-46B5-A147-61C4BE3A7B83Q34712836-4AFB26F5-E3D6-4ABB-A5DE-C442EAE05B1BQ34730407-0463DC04-C93C-4C11-B4F8-E71B00DC7FB2Q35056073-3657E02C-03CA-44E5-B37E-E7DF8FB85BB9Q35084032-1231B9B0-D0F3-434F-AFCC-CF7AF1F842EFQ35182773-DEB5FBD3-5C7B-4BF3-9C9B-4CB07B016C5EQ35206514-FE41237E-C72A-4F0E-A536-6A18E4F12D7DQ35449679-AB050F3B-F6D4-46DF-8E66-CB47EEDBD79EQ35582078-AB8F649A-97A0-4159-9D8B-EF7A12701F19Q35628037-8E0DAC13-3218-418D-A650-6EE31B4CDAC0Q35753555-0A3D45A4-2071-4436-ADAB-895A35C8BDACQ35763057-8F01BA5F-4221-45BE-97AA-9066D4D2C5FFQ35904386-51659F2F-A02B-49D6-852D-E36C03C3E82FQ36149113-5EC9859A-4D40-4493-B7FD-317062357786Q36371970-E240B859-0726-4D25-858C-3A44552FE398Q36422568-42947792-53D5-4992-8B8E-CF00F66A0760Q36543054-7D8611C9-DB5A-49F4-B426-3BBF5782A005Q36735756-CA6EC06E-99EC-4795-804E-50469E86F471Q37207281-E3D23DE5-FED1-4F7E-8958-29EBBBA48C31Q37209892-156E3BE2-89B9-401C-BBBC-B57822D1FEB7Q37321562-1F0F9C21-FC43-4DA9-9B0F-57BA65E2F337Q37748449-ED4003A7-222B-4EF7-BD50-80C1DFC2B901Q37835017-BDDBE2DA-CC57-4AC4-8B1C-A32CAB5B9713Q37846710-254C86D0-1490-4C28-AEC8-A9B655BDD1D2Q37851226-AC909EB6-2756-4CDB-AE33-8B25190F4AB0Q37851309-C84C5A6E-1476-46FB-BDF2-A6E868B5E056Q37851321-CDF1B24F-0453-4649-9CF4-EEA1FBF7FA39Q37853903-78FCB314-4E56-4318-86E9-29181FDEB706Q37855182-1267C1F0-F4C6-4CBE-A939-719A9937A662Q37855685-44615E35-17FF-4984-A573-E2EDCEB6DBB4Q37856124-F36CA81C-76EE-4AA9-85FD-94CAD9B3329EQ37857465-B7CAB4E5-99F9-430B-9564-08089D198523Q37857559-A3BCA098-80BB-4781-ABD2-7BDCB9404521
P2860
Evidence for infectious agents in cardiovascular disease and atherosclerosis.
description
2002 nî lūn-bûn
@nan
2002 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Evidence for infectious agents in cardiovascular disease and atherosclerosis.
@ast
Evidence for infectious agents in cardiovascular disease and atherosclerosis.
@en
Evidence for infectious agents in cardiovascular disease and atherosclerosis.
@nl
type
label
Evidence for infectious agents in cardiovascular disease and atherosclerosis.
@ast
Evidence for infectious agents in cardiovascular disease and atherosclerosis.
@en
Evidence for infectious agents in cardiovascular disease and atherosclerosis.
@nl
prefLabel
Evidence for infectious agents in cardiovascular disease and atherosclerosis.
@ast
Evidence for infectious agents in cardiovascular disease and atherosclerosis.
@en
Evidence for infectious agents in cardiovascular disease and atherosclerosis.
@nl
P1476
Evidence for infectious agents in cardiovascular disease and atherosclerosis.
@en
P2093
Maija Leinonen
Pekka Saikku
P356
10.1016/S1473-3099(01)00168-2
P577
2002-01-01T00:00:00Z